Trump launched a task force to challenge state laws on artificial intelligence, but regulation of the technology is under unclear jurisdiction ...

Newron will host investor and partnering meetings on January 12-14, 2026, coinciding with the 44th Annual J.P. Morgan ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Cytokinetics announced FDA approval of MYQORZO™ (aficamten) to treat adults with symptomatic obstructive hypertrophic ...

New study links childhood maltreatment to genetic changes and higher risks of schizophrenia, ADHD, and depression, ...

I am persuaded to begin this discourse by quoting copiously the late Professor Ben Nwabueze’s position on the concepts of ...

The US Food and Drug Administration has approved aficamten (Myqorzo), an allosteric cardiac myosin inhibitor, for adults with ...

Easing hot flashes, treating rare genetic diseases and a made-in-Canada vaccine among the year’s notable developments ...

The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further ...

Nigeria’s epileptic power sector is throwing more consumers into darkness as grid capacity shrinks to about 3,000 megawatts ...

Nykaa, the beauty and fashion retailer she founded in 2012, was the result of that dissatisfaction and of a banker’s instinct ...

In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...